Suven Life Sciences set to begin samelisant phase 2 trial in narcolepsy

Suven Life Sciences has announced the successful completion of enrollment for its phase-2 proof-of-concept (PoC) clinical study to evaluate the safety and efficacy of samelisant ... Read More